SCHEMBL7839857

SCHEMBL7839857

CCOC(=O)C(c1ccc2c(c1)OCO2)C(C=O)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 2/20 0.43
TRPV1 Q8NER1 2/20 0.42
HPGD P15428 3/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
MAPT P10636 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
HTT P42858 1/20 0.42
AKR1C3 P42330 1/20 0.41
AKR1C2 P52895 1/20 0.41
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40
OGA O60502 3/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7843720 0.90 KDM4E (0.44) KDM4EALDH1A1TRPV1HPGDNPC1
SCHEMBL7841290 0.88 RAB9A (0.46) KDM4EALDH1A1HPGDNPC1RAB9A
SCHEMBL7831716 0.86 RAB9A (0.44) KDM4EALDH1A1TRPV1HPGDNPC1
SCHEMBL7842489 0.86 RAB9A (0.44) KDM4EALDH1A1HPGDNPC1RAB9A
SCHEMBL7839027 0.86 KDM4E (0.49) KDM4EALDH1A1HPGDNPC1RAB9A
SCHEMBL8152135 0.85 KMT2A (0.57) KDM4EALDH1A1NPC1RAB9AMAPT
SCHEMBL7838582 0.85 MAPT (0.55) KDM4EALDH1A1HPGDNPC1RAB9A
SCHEMBL27378630 0.84 CYP3A4 (0.43) KDM4EALDH1A1HPGDNPC1RAB9A
SCHEMBL7842082 0.84 NPC1 (0.44) KDM4EALDH1A1HPGDNPC1RAB9A
SCHEMBL7840091 0.83 CRHBP (0.47) KDM4EALDH1A1HPGDNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882030-B1 2,1,3-BENZOTHIA(OXA)DIAZOLE DERIVATIVES HAVING AN ENDOTHELIN RECEPTOR ANTAGONISTIC EFFECT MERCK PATENT GMBH (DE) 2001-09-12 EP disclosed
US-6017939-A 2,1,3-benzothia(OXA)diazole derivatives having an endothelin receptor antagonistic effect MERCK PATENT GESELLSCHAFT (DE) 2000-01-25 US disclosed
EP-0882030-A1 2,1,3-BENZOTHIA(OXA)DIAZOLE DERIVATIVES HAVING AN ENDOTHELIN RECEPTOR ANTAGONISTIC EFFECT MERCK PATENT GmbH (DE) 1998-12-09 EP disclosed
WO-1997030982-A1 2,1,3-BENZOTHIA(OXA)DIAZOLE DERIVATIVES HAVING AN ENDOTHELIN RECEPTOR ANTAGONISTIC EFFECT MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1997-08-28 WO disclosed